Publication Records

MUNCH, Marie Warrer, Anders GRANHOLM, Jan MALÁSKA, Jan STAŠEK, Pablo O RODRIGUEZ, Tyler PITRE, Rebecca WILSON, Jelena SAVOVIC, Bram ROCHWERG, Adam SVOBODNÍK, Milan KRATOCHVÍL, Manuel TABOADA, Vivekanand JHA, Bharath Kumar Tirupakuzhi VIJAYARAGHAVAN, Sheila Nainan MYATRA, Balasubramanian VENKATESH, Anders PERNER and Morten Hylander MOLLER. Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis. Acta Anaesthesiologica Scandinavica. HOBOKEN: WILEY, 2024, vol. 68, No 2, p. 146-166. ISSN 0001-5172. Available from: https://dx.doi.org/10.1111/aas.14346.

ABSOLONOVÁ, Petra and Jan TRNA. Klinická studie ScrePAN (ScrePAN clinical trial). Florence. Praha: Care Comm, s. r. o., 2024, vol. 3, No 1, p. 12-13. ISSN 1801-464X.

LAKOMÝ, Radek, Martina LOJOVÁ, Lenka SOUČKOVÁ, Ludmila HYNKOVÁ, Kateřina POLÁCHOVÁ, Jiri VASINA, Regina DEMLOVÁ, Alexandr POPRACH, Jiří ŠÁNA, Tomáš PROCHÁZKA, Martin SMRČKA, Pavel FADRUS, Radim JANČÁLEK, Iveta SELINGEROVÁ, Renata BELANOVA, Pavel ŠLAMPA, Petr POSPÍŠIL and Tomáš KAZDA. 11C-methionine in the diagnostics and management of glioblastoma patients with rapid early progression: nonrandomized, open label, prospective clinical trial (GlioMET). BMC Cancer. LONDON: BMC, 2024, vol. 24, No 1, p. 1-16. ISSN 1471-2407. Available from: https://dx.doi.org/10.1186/s12885-024-12469-2.

BAJUS, Adam, Libor STREIT, Tomas KUBEK, Adam NOVÁK, Jiří VANÍČEK, Ondřej ŠEDIVÝ, Andrej BERKEŠ, Kadir Can BAYEZID, Lukáš KUNOVSKÝ and Luboš DRAŽAN. Color Doppler ultrasound versus CT angiography for DIEP flap planning: A randomized controlled trial. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY. OXFORD: ELSEVIER SCI LTD, 2023, vol. 86, November 2023, p. 48-57. ISSN 1748-6815. Available from: https://dx.doi.org/10.1016/j.bjps.2023.07.042.

OBERMANNOVÁ, Radka, Iveta SELINGEROVÁ, Regina DEMLOVÁ, Dalibor VALÍK, Lenka ZDRAŽILOVÁ DUBSKÁ and Igor KISS. CoVigi phase IV multicentric trial evaluating COVID-19 vaccination effectiveness, safety, and immune response dynamics: SARS-CoV-2-specific antibody and T-cell response focused on patients with gastrointestinal tumors. 2023. Available from: https://dx.doi.org/10.1016/j.annonc.2023.04.432.

DEMLOVÁ, Regina, Michaela HANÁKOVÁ, Radka LORDICK OBERMANNOVÁ, Lenka REVILÁKOVÁ, Veronika VÁVROVÁ, Dita KOZÁKOVÁ and Hana BLAHYNKOVÁ. Den s koordinátorkou klinických studií (A day with the clinical studies coordinator). NA. Brno: Masarykův onkologický ústav, 2023.

DEMLOVÁ, Regina and Kateřina NERUŠILOVÁ. DEVELOPMENT SAFETY UPDATE REPORT FDG PET 15.10.2022 – 14.10.2023. NA. Brno: MU LF/MŠMT/MOÚ, 2023, 14 pp. NA.

DEMLOVÁ, Regina and Michaela KUBELOVÁ. DEVELOPMENT SAFETY UPDATE REPORT RASMIR 1.8.2022– 31.7.2023. NA. Brno: MU LF/MŠMT/MOÚ, 2023, 16 pp. NA.

DEMLOVÁ, Regina and Kateřina NERUŠILOVÁ. DEVELOPMENT SAFETY UPDATE REPORT 2023 GLIOMET. NA. Brno: MU LF/MOÚ, 2023, 17 pp. NA.

LORDICK OBERMANNOVÁ, Radka and Lenka SOUČKOVÁ. New clinical trials regulation targeted for early phase trials. 2023.

DEMLOVÁ, Regina, Lenka SOUČKOVÁ, Iveta SELINGEROVÁ and Adam SVOBODNÍK. PharmAround / CZECRIN workshop. 2023.

DEMLOVÁ, Regina. Průběžná zpráva o klinickém hodnocení léčiva RASmiR 01.08.2022 – 31.07.2023 (Interim Report on Clinical Drug Evaluation RASmiR 01.08.2022 – 31.07.2023). NA. Brno: MU LF/MŠMT/MOÚ, 2023, 4 pp. NA.

DEMLOVÁ, Regina and Kateřina JANSKÁ. ZPRÁVA O ŘÁDNÉM UKONČENÍ KLINICKÉHO HODNOCENÍ CoVigi (TERMINATION REPORT OF THE CoVigi CLINICAL EVALUATION). NA. Brno: MU LF/MŠMT/MOÚ, 2023, 4 pp. NA.

DEMLOVÁ, Regina, Radka OBERMANNOVÁ, Martina LOJOVÁ and Hana VLADÍKOVÁ. 5. setkání CZECRIN ONCO (5th CZECRIN ONCO meeting). 2023.

DEMLOVÁ, Regina, Martina LOJOVÁ, Šárka SELVEKEROVÁ, Michaela HANÁKOVÁ, Lucie SKŘIČKOVÁ and Hana VLADÍKOVÁ. 6. celostátní setkání studijních sester a koordinátorů klinických hodnocení (6th National meeting of study nurses and coordinators of clinical evaluations). 2023.

DEMLOVÁ, Regina and Radka OBERMANNOVÁ. 6. setkání CZECRIN ONCO (6th CZECRIN ONCO meeting). 2023.

LANDA, Leoš, Vaclav TROJAN, Regina DEMLOVÁ, Jan JUŘICA and Radovan HRIB. Cannabidiol and the possibilities of its use in veterinary medicine of dogs and horses: A brief review. VETERINARNI MEDICINA. Praha: Ústav zemědělských a potrav. informací, 2022, vol. 67, No 9, p. 455-462. ISSN 0375-8427. Available from: https://dx.doi.org/10.17221/127/2021-VETMED.

DEMLOVÁ, Regina, Jiří DEML and Radka OBERMANNOVÁ. CZECRIN/PharmAround workshop. 2022.

DEMLOVÁ, Regina and Michaela KUBELOVÁ. Průběžná zpráva o klinickém hodnocení léčiva (Interim Report on Clinical Drug Evaluation). MU LF/MŠMT/MOÚ, 2022.

OBERMANNOVÁ, Radka, Regina DEMLOVÁ, Martina LOJOVÁ and Hana VLADÍKOVÁ. 3. setkání CZECRIN ONCO (3rd CZECRIN ONCO MEETING). 2022.

DEMLOVÁ, Regina, Radka OBERMANNOVÁ, Martina LOJOVÁ and Hana VLADÍKOVÁ. 4. setkání CZECRIN ONCO (4th CZECRIN ONCO meeting). 2022.

DEMLOVÁ, Regina, Jiří DEML, Martina LOJOVÁ, Šárka SELVERKEROVÁ and Michaela HANÁKOVÁ. 5. celostátní setkání studijních sester a koordinátorů klinických hodnocení (5th national meeting of study nurses and coordinators of clinical evaluations). 2022.

HALÁMKOVÁ, Jana, Dagmar KRÁKOROVÁ and Regina DEMLOVÁ. Anizokorie jako nežádoucí účinek léčby paklitaxelem (Anisocoria as a side effect of paclitaxel treatment). Časopis Klinická onkologie. Praha: Česká lékařská společnost J. E. Purkyně, 2021, vol. 34, No 4, p. 306-308. ISSN 0862-495X. Available from: https://dx.doi.org/10.48095/ccko2021306.

DEMLOVÁ, Regina and Radka OBERMANNOVÁ. COVID-19 POST-VACCINATION ANTIBODY AND CELLULAR IMMUNITY DYNAMICS IN CANCER PATIENTS ON ACTIVE ONCOLOGY TREATMENT – FIRST RESULTS OF PHASE IV MULTICENTRIC COVIGI STUDY. In 45. ročník Brněnských onkologických dnů. 2021.

OBERMANNOVA, R., Regina DEMLOVÁ, I. SELINGEROVA, M. DOUBEK, D. OKROUHLICOVA, Marie MLNAŘÍKOVÁ, Kateřina PILÁTOVÁ, Jiří NEVRLKA, Hana LEJDAROVÁ, B. WEINBERGEROVA, Z. CERMAKOVA, Dalibor VALÍK, Jiří MAYER, Igor KISS and Lenka ZDRAŽILOVÁ DUBSKÁ. CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity. In Congress of the European Society for Medical Oncology ESMO 2021. 2021. ISSN 0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2021.08.1556.

DEMLOVÁ, Regina. DEVELOPMENT SAFETY UPDATE REPORT Sequential FDG PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago Gastric Cancer Phase II Period covered: 15.10.2020 – 14.10.2021. Brno: MOÚ, 2021, 3 pp. NA.

SELINGEROVÁ, Iveta, Dalibor VALÍK, Lenka GESCHEIDTOVÁ, Vladimír ŠRÁMEK, Z. CERMAKOVA and Lenka ZDRAŽILOVÁ DUBSKÁ. Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI. Journal of Medical Virology. Hoboken: Wiley, 2021, vol. 93, No 3, p. 1805-1809. ISSN 0146-6615. Available from: https://dx.doi.org/10.1002/jmv.26612.

BOSSI, P., A. T. CHAN, L. LICITRA, A. TRAMA, E. ORLANDI, E. P. HUI, Jana HALÁMKOVÁ, S. MATTHEIS, B. BAUJAT, J. HARDILLO, L. SMEELE, C. VAN HERPEN, A. CASTRO and J. P. MACHIELS. Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology. AMSTERDAM: Oxford University Press, 2021, vol. 32, No 4, p. 452-465. ISSN 0923-7534. Available from: https://dx.doi.org/10.1016/j.annonc.2020.12.007.

HOLÁNEK, Miloš, Iveta SELINGEROVÁ, Ondřej BÍLEK, Tomáš KAZDA, Pavel FABIAN, Lenka FORETOVÁ, Mária ZVARÍKOVÁ, Radka OBERMANNOVÁ, Ivana KOLOUŠKOVÁ, Oldřich COUFAL, Katarína PETRÁKOVÁ, Marek SVOBODA and Alexandr POPRACH. Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence. Cancers. BASEL: MDPI, 2021, vol. 13, No 7, p. 1-19. ISSN 2072-6694. Available from: https://dx.doi.org/10.3390/cancers13071586.

ADÁMKOVÁ KRÁKOROVÁ, Dagmar, Jana HALÁMKOVÁ, Štěpán TUČEK, Ondřej BÍLEK, Jan KRISTEK, Tomáš KAZDA, Iva ZAMBO, Regina DEMLOVÁ and Igor KISS. Penis as a primary site of an extraskeletal Ewing sarcoma A case report. Medicine. Philadelphia: Lippincott Williams & Wilkins, 2021, vol. 100, No 11, p. 1-5. ISSN 0025-7974. Available from: https://dx.doi.org/10.1097/MD.0000000000025074.

OBERMANNOVÁ, Radka, Iveta SELINGEROVÁ, Zdeněk ŘEHÁK, Václav JEDLIČKA, Marek SLÁVIK, Pavel FABIAN, Ivo NOVOTNÝ, Milada ZEMANOVA, Hana STUDENTOVA, Peter GRELL, Lenka ZDRAŽILOVÁ DUBSKÁ, Regina DEMLOVÁ, Tomáš HARUSTIAK, Renata HEJNOVA, Igor KISS and Rostislav VYZULA. PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY. LONDON: SAGE PUBLICATIONS LTD, 2021, vol. 13, December 2021, p. 1-14. ISSN 1758-8340. Available from: https://dx.doi.org/10.1177/17588359211065153.

HALÁMKOVÁ, Jana, Tomáš KAZDA, Lucie PEHALOVÁ, Roman GONĚC, Šárka KOZÁKOVÁ, Lucia BOHOVICOVÁ, Dagmar KRAKOROVA ADAMKOVA, Ondřej SLABÝ, Regina DEMLOVÁ, Marek SVOBODA and Igor KISS. Second primary malignancies in colorectal cancer patients. Nature Scientific Reports. London: NATURE RESEARCH, 2021, vol. 11, No 1, p. 1-12. ISSN 2045-2322. Available from: https://dx.doi.org/10.1038/s41598-021-82248-7.

HALÁMKOVÁ, Jana, Tomáš KAZDA, Lucie PEHALOVÁ, Roman GONĚC, Sarka KOZAKOVA, Lucia BOHOVICOVA, Ondřej SLABÝ, Regina DEMLOVÁ, Marek SVOBODA and Igor KISS. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients. Frontiers in Oncology. Lausanne: Frontiers Media S.A., 2021, vol. 10, January 2021, p. 1-10. ISSN 2234-943X. Available from: https://dx.doi.org/10.3389/fonc.2020.573394.

DEMLOVÁ, Regina and Michaela KUBELOVÁ. Zpráva o průběhu klinického hodnocení „RASmiR" Racionální výběr Anti-EGFR terapie v první linii léčby pacientů s metastazujícím kolorektálním karcinomem wild-type KRAS / NRAS na základě použití molekulárního prediktoru miR-31-5p (Clinical Trial Interim Report: „RASmiR" Rational Anti-EGFR therapy Selection for the first-line treatment of patients with metastatic KRAS/NRAS wild type colorectal cancer based on the use of molecular predictor miR-31-5p). NA. Brno: MU LF/MŠMT, 2020, 4 pp. NA.

DEMLOVÁ, Regina and Michaela KUBELOVÁ. Zpráva o průběhu klinického hodnocení "Sequential FDG-PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago-Gastric Cancer; (GastroPET); EudraCT: 2017-001264-38 (Clinical Trial "Sequential FDG-PET and Plasma/Tissue miRNA as a Biomarkers of Preoperative Treatment Strategy in Locally Advanced Oesophago-Gastric Cancer; (GastroPET)" Interim Report). NA. Brno: MU LF/MŠMT, 2020, 3 pp. NA.

BENCSIKOVA, B., E. BUDINSKA, I. SELINGEROVÁ, K. PILATOVA, L. FEDOROVA, K. GREPLOVA, R. NENUTIL, Dalibor VALÍK, Radka OBERMANNOVÁ, M.A. SHEARD and L. ZDRAZILOVA DUBSKA. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness. BMC Cancer. London: BioMed Central, 2019, vol. 19, No 687, p. 1-9. ISSN 1471-2407. Available from: https://dx.doi.org/10.1186/s12885-019-5909-5.

MALÚŠKOVÁ, Denisa, Ivana SVOBODOVÁ, Michaela ZAPLETALOVÁ, Lucie BROŽOVÁ, Jan MUŽÍK, Jiří JARKOVSKÝ, R. HÁJEK, V. MAISNAR and Ladislav DUŠEK. Epidemiology of Multiple Myeloma in the Czech Republic. Klinická onkologie. Praha: Ambit Media, 2017, vol. 30, Suppl. 2, p. "2S35"-"2S42", 8 pp. ISSN 0862-495X. Available from: https://dx.doi.org/10.14735/amko20172S35.

DUCHNOWSKA, Renata, Jeff SPERINDE, Bogumiła CZARTORYSKA-ARŁUKOWICZ, Paulina MYŚLIWIEC, John WINSLOW, Barbara RADECKA, Christos PETROPOULOS, Regina DEMLOVÁ, Marlena ORLIKOWSKA, Anna KOWALCZYK, Istvan LANG, Barbara ZIÓŁKOWSKA, Sylwia DĘBSKA-SZMICH, Monika MENDALSKA, Aleksandra GRELA- WOJEWODA, Anton ŻAWROCKI, Wojciech BIERNAT, Weidong HUANG and Jacek JASSEM. Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab. Oncotarget. New York: Impact Journals, 2017, vol. 8, No 61, p. 104149-104159. ISSN 1949-2553. Available from: https://dx.doi.org/10.18632/oncotarget.22027.